-
1 Comment
A-Labs Capital II Corp is currently in a long term downtrend where the price is trading 0.0% below its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Financial Services sector with a price to sales ratio of 0.0.
A-Labs Capital II Corp's total revenue sank by nan% to $0 since the same quarter in the previous year.
Its net income has increased by 11.2% to $-21K since the same quarter in the previous year.
Finally, its free cash flow fell by 1406.4% to $-14K since the same quarter in the previous year.
Based on the above factors, A-Labs Capital II Corp gets an overall score of 2/5.
| ISIN | None |
|---|---|
| Industry | Shell Companies |
| Sector | Financial Services |
| CurrencyCode | CAD |
| Exchange | V |
| Dividend Yield | 0.0% |
|---|---|
| Beta | -0.21 |
| Target Price | None |
| PE Ratio | None |
| Market Cap | 663K |
A-Labs Capital II Corp. does not have significant operations. It intends to identify and evaluate assets or businesses with a view to complete a qualifying transaction in the software, hardware, and biotech sectors. The company was incorporated in 2018 and is headquartered in Vancouver, Canada.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for ALAB-P.V using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024
